Clinical trial
U01 Cooperative Assessment of Late Effects for Sickle Cell Disease Curative Therapies
NCT05153967 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- U01 Cooperative Assessment of Late Effects for Sickle Cell Disease Curative Therapies
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 12, 2022
- Completion date
- February 28, 2027
- Enrollment
- 377 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
heart disease, pulmonary disease, renal disease, sickle cell disease